Today, we offer a comprehensive portfolio of SARS-CoV-2 testing solutions, covering the needs of clinical and research customers. Our tests and kits cover manual to automated sample processing, low to high throughput, single-plex to multi-plex, and from active infection testing to detecting previous viral exposure.
Confronting emerging COVID-19 variants
Customers stepping up to the challenge
Our customers are the real heroes stepping up to take on COVID-19 challenges. Read more about how they are unlocking answers and driving COVID-19 discovery and diagnostics.
We have developed a comprehensive portfolio of COVID-19 diagnostic testing solutions including targeted and multiplex PCR detection and rapid antibody tests. We also support several testing protocols by providing test components and mid- to high-throughput automation solutions.
Pandemics require accelerated development of innovative technologies to provide rapid and effective responses. QIAGEN supports scientists seeking to better understand the SARS-CoV-2 virus with research tools. Our portfolio includes a full spectrum of our high-performance NGS solutions and integrated bioinformatics pipelines that collectively drive a greater understanding of the multiple facets of SARS-CoV-2 biology.